Altered spinogenesis in iPSC-derived cortical neurons from patients with autism carrying de novo SHANK3 mutations

• Published in: Scientific reports 2019-01, Vol.9 (1), p.94-94, Article 94
• Main Authors: Gouder, Laura, Vitrac, Aline, Goubran-Botros, Hany, Danckaert, Anne, Tinevez, Jean-Yves, André-Leroux, Gwenaëlle, Atanasova, Ekaterina, Lemière, Nathalie, Biton, Anne, Leblond, Claire S., Poulet, Aurélie, Boland, Anne, Deleuze, Jean-François, Benchoua, Alexandra, Delorme, Richard, Bourgeron, Thomas, Cloëz-Tayarani, Isabelle
• Format: Article
• Language: English
• Subjects: 13/100; 13/106; 13/44; 13/51; 14/19; 38; 38/39; 38/90; 45/91; 631/378/2597; 631/45/500; 631/80; Autism; Autistic Disorder - genetics; Autistic Disorder - pathology; Cell Differentiation; Dendrites - pathology; Dendritic spines; Filopodia; Humanities and Social Sciences; Humans; Immunofluorescence; Induced Pluripotent Stem Cells - physiology; Life Sciences; Microscopy, Fluorescence; mRNA; multidisciplinary; Mutation; Nerve Tissue Proteins - deficiency; Nerve Tissue Proteins - genetics; Neural stem cells; Pluripotency; Postsynaptic density; Pyramidal cells; Pyramidal Cells - cytology; Pyramidal Cells - pathology; Science; Science (multidisciplinary); Sequence Deletion; Spine; Stem cells; Synapses
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-018-36993-x

The synaptic protein SHANK3 encodes a multidomain scaffold protein expressed at the postsynaptic density of neuronal excitatory synapses. We previously identified de novo SHANK3 mutations in patients with autism spectrum disorders (ASD) and showed that SHANK3 represents one of the major genes for ASD. Here, we analyzed the pyramidal cortical neurons derived from induced pluripotent stem cells from four patients with ASD carrying SHANK3 de novo truncating mutations. At 40–45 days after the differentiation of neural stem cells, dendritic spines from pyramidal neurons presented variable morphologies: filopodia, thin, stubby and muschroom, as measured in 3D using GFP labeling and immunofluorescence. As compared to three controls, we observed a significant decrease in SHANK3 mRNA levels (less than 50% of controls) in correlation with a significant reduction in dendritic spine densities and whole spine and spine head volumes. These results, obtained through the analysis of de novo SHANK3 mutations in the patients’ genomic background, provide further support for the presence of synaptic abnormalities in a subset of patients with ASD.